Sooyeon Kwon

Nov 5, 2024 | medcentral.com | Sooyeon Kwon

The pharmacotherapeutic approach to systemic lupus erythematosus (SLE) varies depending upon the patient’s symptoms, disease severity, organs involved, and other patient-specific issues such as reproduction planning. Treatment, therefore, must be individualized and include education, counseling, and shared decision-making.1SLE treatment goals include early control of disease activity, prevention of disease flares, and minimizing treatment-related toxicity.

Oct 10, 2024 | medcentral.com | Sooyeon Kwon

Although the etiology of immunoglobulin G4-related disease (IgG4-RD) is complex and not yet fully understood,1 it is believed to be caused by persistent inflammation from antigenic stimuli. After the immune system recognizes an antigenic agent or agents (eg, autoantigens, infectious agents, or allergens), the adaptive immune system activates a B- and T-cell response forming plasmablasts, Tfh cells, Tph cells, and CD4+ cytotoxic T-cells (CD4+CTL).

Feb 22, 2024 | mdpi.com | Sooyeon Kwon |Marc A. Judson |In Albany

All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.